New

Global ETF Survey 2026: Answer now →

Help us improve your experience. Please confirm your investor type:

Global ETF Survey 2026

The ETF Industry Is Evolving Fast

From AI infrastructure to active strategies, the ETF landscape is shifting. Share your perspective in the 7th Annual Global ETF Survey.

Global ETF Survey 2026
Advertisement
Advertisement
›Stocks›1093

ETFs with exposure to CSPC Pharmaceutical Group Ltd. (1093)

259 ETFs hold CSPC Pharmaceutical Group Ltd. (1093)
Holdings data as of May 31, 2026
Roundhill GLP-1 & Weight Loss ETF - USD
This ETF provides exposure to Other Equities
4.57%
+3.78%
-5.57%
+€2.5M
+€12M
€47M
0.59%
Not rated
Amplify Weight Loss Drug & Treatment ETF - USD
This ETF provides exposure to Equities
4.09%
+5.42%
+1.56%
€0
+€1.3M
€3.8M
0.59%
Not rated
KraneShares MSCI All China Health Care Index ETF - USD
This ETF provides exposure to Large and Mid-Cap Chinese Health Care Equities
3.79%
+0.44%
-6.93%
+€19K
+€1.2M
€64M
0.79%
Chimera S&P China HK Shariah ETF - HKD
This ETF provides exposure to Equities
1.13%
-16.12%
-26.12%
€0
€0
€3.8M
1%
Not rated
Cambria Emerging Shareholder Yield ETF - USD
This ETF provides exposure to Equally Weighted Emerging markets Equities
0.81%
-3.97%
+19.45%
+€34M
+€71M
€716M
0.65%
Not rated
Amundi MSCI China ESG Selection Extra UCITS ETF Dist - EUR
This ETF provides exposure to Large and Mid-Cap Chinese Equities
Share class
Dist
EUR
0.55%
-7.44%
-13.22%
-€3.1M
-€41M
€86M
0.65%
Not rated
Amundi MSCI China ESG Selection Extra UCITS ETF Acc - EUR
This ETF provides exposure to Large and Mid-Cap Chinese Equities
Share class
Acc
EUR
0.55%
-7.14%
-12.94%
-€38M
-€64M
€372M
0.65%
Not rated
iShares Dow Jones China Offshore 50 UCITS ETF (DE) - USD
This ETF provides exposure to Large Cap Chinese Equities
0.54%
-11.13%
-19.16%
€0
-€6.1M
€38M
0.62%
RAFI Dynamic Multi-Factor Emerging Markets Equity ETF - USD
This ETF provides exposure to Other Emerging markets Equities
0.50%
-10.24%
+18.61%
€0
+€8.6M
€128M
0.5%
BMO MSCI China Selection Equity Index ETF - CAD
This ETF provides exposure to Large and Mid-Cap Chinese Equities
0.47%
-6.97%
-16.30%
€0
+€1.9M
€69M
0.67%
See more results with a Trackinsight account
Get started with a free Essentials account today.
Trackinsight

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy  |  Cookie policy  |    |  Terms of use  |  Imprint
Trackinsight